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Abstract
Population structure occurs when a sample is composed of individuals with different ancestries and
can result in excess type I error in genome-wide association studies. Genome-wide principal-
component analysis (PCA) has become a popular method for identifying and adjusting for subtle
population structure in association studies. Using the Genetic Analysis Workshop 16 (GAW16)
NARAC data, we explore two unresolved issues concerning the use of genome-wide PCA to
account for population structure in genetic associations studies: the choice of single-nucleotide
polymorphism (SNP) subset and the choice of adjustment model. We computed PCs for subsets of
genome-wide SNPs with varying levels of LD. The first two PCs were similar for all subsets and the
first three PCs were associated with case status for all subsets. When the PCs associated with case
status were included as covariates in an association model, the reduction in genomic inflation factor
was similar for all SNP sets. Several models have been proposed to account for structure using PCs,
but it is not yet clear whether the different methods will result in substantively different results for
association studies with individuals of European descent. We compared genome-wide association
p-values and results for two positive-control SNPs previously associated with rheumatoid arthritis
using four PC adjustment methods as well as no adjustment and genomic control. We found that in
this sample, adjusting for the continuous PCs or adjusting for discrete clusters identified using the
PCs adequately accounts for the case-control population structure, but that a recently proposed
randomization test performs poorly.
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Background
Cases for the North American Rheumatoid Arthritis
Consortium (NARAC) study were collected across the
United States; controls were collected from Long Island,
NY [1]. Because of the differences in the mix of European
ancestry across the US, we expect to see population
structure in the Genetic Analysis Workshop 16 (GAW16)
NARAC sample. Population structure can lead to
spurious association when the distributions of both the
trait and the genotype of interest vary among subpopu-
lations. Even modest differences among subpopulations
can lead to spurious associations in large samples:
population structure bias is of particular concern for
genome-wide studies in which large numbers of subjects
are needed to detect modest effects of a single-nucleotide
polymorphism (SNP) with the phenotype [2].
Several methods have been developed to detect and
adjust for population structure, including genomic
control [3], structured association [4], and genome-
wide principal-components analysis (PCA) [5,6]. Here,
we focus on the PCA approach. The principal compo-
nents (PCs) are computed using the genotype matrix
from genome-wide SNP data, where each SNP genotype
is a count (0, 1, or 2) of the number of copies of the
minor allele [5,6]. Each PC is a weighted sum of all SNP
genotype counts. The first PC accounts for the largest
proportion of genetic variation; each additional PC
accounts for successively smaller proportions. The PCs
have been shown to capture genetic differences among
individuals of European heritage due to ancestry [7].
These components can be used as covariates in an
association analysis to account for differences in ancestry
among individuals [6].
When limited numbers of SNPs are available to
compute the PCs, each SNP will contribute a greater
proportion of information to the PCA. In this situation,
SNPs in strong linkage disequilibrium (LD) may have
excessive influence on one or a set of PCs [5]. However,
it is not clear whether the same issue arises in the
context of dense genome-wide SNPs, where some
investigators have advocated for the use of all SNPs to
compute the PCs [5], while others have proposed the
use of a subset of SNPs in linkage equilibrium [8]. In
previous analyses of the NARAC data set, investigators
noted that the third and fourth PCs from a genome-
wide PCA heavily weighted SNPs within a 3.8-Mb
region on 8p23 with a known inversion polymorphism
[1], and advocated the omission of SNPs in this region,
as well as the MHC region that is strongly associated
with RA. Thus, conflicting views remain on how best to
select a set of SNPs to use for PCA for the purpose of
adjustment for population structure in genetic associa-
tion studies.
In addition to the controversy concerning choice of SNPs
for PCA, investigators have proposed several methods to
adjust for the structure. The developers of the computer
program EIGENSTRAT recommend adjustment for the
PCs as linear covariates in an association model, while
other investigators have proposed approaches that
cluster individuals, arguing that the PCs, phenotype,
and allele frequencies may not be linearly related,
particularly when the PCs create distinct clusters [9].
Kimmel et al. propose a randomization test as an
alternative to adjusting for PCs within a traditional
regression framework [10]. Using simulation, they show
that their population structure association test (PSAT) is
considerably more powerful than the linear adjustment
approach of EIGENSTRAT in some situations [10]. It is
unclear whether the proposed approaches will result in
substantively different results in typical genome-wide
association studies using individuals of European
ancestry.
To address these questions, we compare six choices for
subsetting SNPs for PCA, and four methods for adjusting
for structure identified using PCA, as well as no
adjustment and genomic control, using the NARAC
rheumatoid arthritis (RA) genome-wide SNP data
provided by GAW16. Our goal is to determine to what
extent SNP choice and method of population structure
adjustment affects the results of the genome-wide
association study, measured by the genomic control
inflation factor, and by specific association results for
previously reported positive associations between SNPs
and RA [11-13].
Methods
Quality control
GAW16 NARAC samples (868 cases, 1194 controls) were
genotyped using the Illumina 550 k chip. All subjects
had fewer than 10% missing genotypes. Seven subjects
had X chromosome heterozygosity incompatible with
their phenotypic sex (homozygosity > 0.2 for females or
<0.8 for males) [14] and were omitted from all analyses.
We excluded SNPs with departure from Hardy-Weinberg
equilibrium in controls (p < 10-6), ≥ 2% missing
genotypes, or minor allele frequency <0.01, leaving a
total of 470,943 autosomal SNPs.
SNP subsets for PCA
We computed the genotypic PCs using the 2055 NARAC
individuals for six subsets of SNPs: (S1) all SNPs passing
quality control ("filtered SNPs”), (S2) filtered SNPs,
omitting SNPs in the MHC region, (S3) filtered SNPs
omitting SNPs in the MHC region and the inversion
polymorphism on chromosome 8, (S4) filtered SNPs
omitting all of chromosome 6 and the inversion
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polymorphism on chromosome 8, (S5) filtered SNPs
omitting one SNP from each pair of SNPs having allelic
correlation r2 > 0.4 [14], and (S6) filtered SNPs omitting
one SNP from each pair of SNPs with r2 > 0.2.
For SNP Sets (S2) and (S3), we omitted all SNPs within
10 kb of 6q21.3 [15], the MHC region that is highly
associatedwith RA.We defined the chromosome8 inversion
polymorphism as the region spanning 8 Mb to 11.5 Mb [1].
Previous studies have omitted these regions when conduct-
ing genome-wide PCA to avoid bias due to a region strongly
linked to case-status, and a region with known high LD and
extreme PC SNP weights, respectively [1].
Adjustment for structure in association analyses
To simplify presentation, we selected a single SNP subset
(S3, filtered SNPs omitting MHC and inversion poly-
morphism SNPs) for exploration of adjustment methods
(see Results for rationale for the choice of Set S3). We
determined the distributions of genome-wide p-values
excluding the highly associated MHC region and
association results for two specific SNPs that have been
reported to be associated with RA: rs2476601 [11,12]
and rs3761847 [1] for six models: (A) logistic regression
adjusting for the DRB locus (no adjustment for
structure), (B) logistic regression adjusting for the DRB
locus and PC1-4 as continuous covariates, (C) logistic
regression adjusting for the DRB locus and the five
clusters obtained by clustering, (D) logistic regression
adjusting for the DRB locus, PC1-4 as continuous
covariates, and the five PC clusters, (E) PSAT [10] with
disease probability assigned based on the five PC-based
clusters, and (F) genomic control using the logistic
model adjusting for the DRB locus. For all analyses, we
coded the SNP genotype as the count of the number of
minor alleles. This model assumes a linear relationship
between the log odds of case status and the number of
minor SNP alleles. The first four PCs for SNP Subset (S3)
were associated with RA status (Wilcoxon rank sum test
p-value < 0.05); we therefore used these PCs for
adjustment and clustering in association analyses [Meth-
ods (B)-(E)]. For association Models (C), (D), and (E)
we used the partitioning around medoids algorithm
("pam” function in R [16]) to cluster the individuals
using the four PCs associated with RA case status. A five-
cluster solution was optimal based on silhouette widths.
The DRB locus is defined as the number of high- and
medium-risk alleles each individual carried [15].
Logistic regression analyses [Models (A)-(D)] were
performed using the computer program PLINK [14]
and analysis for Method (E) was performed using the
PSAT software [10]. PSAT tests the association between a
SNP and disease, accounting for population structure
using a randomization test. The user specifies the
probability of being a case for each cluster based on
ancestry information. For each replicate, case status for
each individual is re-assigned at random according to the
baseline probability for the cluster to which the
individual is assigned. The probabilities of disease and
sample sizes in the five clusters were 0.08 (n = 77), 0.11
(n = 68), 0.12 (n = 460), 0.37 (n = 230), and 0.63
(1120). One million samplings were used to assess
significance.
Results
SNP subsets
For each SNP subset, PC1-3 are highly associated with
case status (two-sample Wilcoxon test p < 0.05; Table 1).
Association of other PCs with case status varied depend-
ing on the subset. PC1 and PC2 for the S3 subset, which
excluded the MHC region and the inversion polymorph-
ism on chromosome 8, are highly correlated with the
corresponding PC in all other subsets (square of the
Pearson correlation coefficient r2 > 0.94). For each of
the remaining S3 PCs, we display in Table 2 the PCs
from the other SNP subsets that are correlated with r2 >
0.15. Subset S3 PC3 and PC4 were highly correlated with
the same PCs for subsets S4-S6 (r2: 0.83-0.98). For
Subset S2, PC3 and PC4 appear to take the place of S3
PC3. The correlations between the S3 PCs and PC3-PC10
obtained from the minimally filtered SNP Set S1 are
weaker and less consistent. We examined the SNP
weights to understand why some PCs in different subsets
are not strongly correlated. SNPs in the MHC region on
chromosome 6 were assigned large weights for PCs 1 and
2 in the S1 subset. Removal of SNPs in this region (S2,
S3, and S4), or general removal of SNPs in LD across the
genome (S5, S6) reduced the problem of extreme
weights on chromosome 6 (Figure 1). SNPs in the
inversion region on chromosome 8 were assigned
extreme weights for PC3 and PC4 for SNP Subsets S1
and S2 (Figure 1). SNP subsets omitting this region (S3,
S4) or omitting SNPs in LD (S5, S6) showed no evidence
for overweighting on chromosome 8. The four PCs
associated with RA status in the subsets that removed the
MHC region and the chromosome 8 inversion, (S3 and
S4), or filtered out SNPs in high LD (S5 and S6)
exhibited minimal extreme SNP weights across the
genome other than a small region on chromosome 2
that contains the lactase gene (LCT), which is known for
strong structure in European populations [17].
Adjustment for structure
When using PCA to account for population structure, the
primary goal is to reduce type I error to the nominal
(expected) level without reducing power for true positive
associations. The genomic control inflation factor (l),
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defined as the median association test statistic across all
SNPs divided by its expected value, is an overall
indicator of the inflation in the test statistics [4]. We
computed l for genome-wide analyses excluding the
MHC region, adjusting for the PCs significantly asso-
ciated with RA at a = 0.05 as linear covariates. For the six
SNP subsets, l ranged between 1.022 and 1.030,
indicating good control of inflation compared to the
substantial inflation (l = 1.24) observed for analyses
unadjusted for structure (Table 1).
Linear adjustment for PCs to account for population
structure has been shown to have lower power and higher
type I error than alternatives in some situations [9,10],
therefore we explored other methods for adjusting for
structure. To simplify presentation, we selected a single
SNP subset (S3) for exploration of adjustment methods.
SNP Sets S1 and S2 produced several PCs that were
significantly associated with RA and also had heavily
weighted SNPs in some genomic regions (Figure 1).
Because heavy weights in a regionwill reduce the power to
detect true associations with SNPs in that region, we
selected the S3 SNP subset, which used the maximum
number of SNPs to determine the PCs while minimizing
overweighting of SNPs in any region.
Table 1: Summary of PCA with six SNP subsets
SNP Subset for PCA No.
SNPs
PCs significantly associated with RA (a = 0.05) la
S1. Filtered SNPs 459,422 1, 2, 3, 5, 6, 8, 9 1.023
S2. Removing the MHC region 457,776 1, 2, 3, 5 1.027
S3. Removing MHC and inversion on chr 8 456,846 1, 2, 3, 4 1.028
S4. Removing chr 6 and inversion on chr 8 427,806 1, 2, 3, 4 1.030
S5. Removing LD between SNPs with r2 > 0.4 164,418 1, 2, 3, 4 1.022
S6. Removing LD between SNPs with r2 > 0.2 81,240 1, 2, 3, 4, 5 1.023
aInflation factor for genome-wide SNP association test statistics adjusting for PCs significantly associated with RA at (a = 0.05) as linear covariates.
Table 2: Correlation between S3 PCs and other SNP subset PCs
PCA removing MHC and inversion on chromosome 8 (S3)b
Subset PC3 PC4 PC5 PC6 PC7 PC8 PC9 PC10
S1 PC3, PC4
(0.32,0.66)
PC5, PC6
(0.55, 0.81)
PC5, PC6
(0.46, 0.27)
PC7
(0.92)
PC8, PC9, PC10
(0.35, 0.25, 0.37)
PC9
(0.20)
—— ——
S2 PC3, PC4
(0.29, 0.72)
PC5
(0.98)
PC6
(0.98)
PC7
(0.98)
PC8
(0.99)
PC9
(0.98)
PC10
(0.96)
——
S4 PC3
(0.98)
PC4
(0.98)
——c PC5
(0.92)
PC6
(0.85)
PC7, PC8
(0.61, 0.18)
PC7, PC8
(0.16, 0.58)
PC9
(0.66)
S5 PC3
(0.96)
PC4
(0.90)
—— —— —— —— —— ——
S6 PC3
(0.92)
PC4
(0.83)
—— —— —— —— —— ——
aFor each SNP subset, the PCs correlated with the corresponding subset S3 PC with r2 > 0.15 are displayed, along with the r2 value.
bPC1 and PC2 for each subset are correlated with S3 subset PC1 and PC2 (r2 > 0.98, r2 > 0.94), and are not shown.
c—, No PC has correlation (r2 > 0.15) with the S3 subset PC.
Figure 1
PCA plot of SNP weights. Plot of SNP weights from PCAs
S1 (black), S2 (red), S3 (green), S5 (blue), and S6 (turquoise).
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For the genome-wide results excluding the MHC region,
we compared the genomic control inflation factor (l) for
adjustment Methods (B)-(E) to the unadjusted Model
(A). The inflation factor was 1.24 for the unadjusted
logistic regression, 1.03-1.04 for the PC-adjusted logistic
regression analyses, and 1.15 for the PSAT analysis
(Figure 2). These findings suggest that adjusting either
for PC1-PC4 or the cluster assignments based on PC1-
PC4 considerably reduces the inflation in the test
statistic, but that adjusting for both PC1-PC4 and cluster
membership does not further reduce the inflation for
these data. The PSAT randomization test also reduces the
inflation, but not nearly as well as the less computer
intensive approaches for adjusting for structure. The
association results for two SNPs previously found to be
associated with RA are displayed in Table 3. Both SNPs
have differences of more than 0.15 in allele frequencies
across HapMap populations, and are therefore also likely
to have allele frequency differences across European
populations. All adjustment methods reduce the sig-
nificance of the SNPs but still provide evidence for
association.
Conclusion
We performed PCA for six subsets of genome-wide
SNPs; the first two PCs were similar for all subsets, and
were highly associated with RA case status. The third
and fourth PCs were very similar for SNP sets that either
removed all SNPs in LD or removed the chromosome 8
inversion region known for high LD. SNP sets that
included all SNPs had SNPs with extreme weights for
some PCs. In this data set, structure adjustment using
PCs obtained from any of the SNP subsets similarly
reduces the genomic inflation factor. However, SNP sets
that result in PCs that over-weight a genomic region
may be prone to loss of power because strong PC
weights on a true-positive SNP may adjust away the SNP
effect.
We evaluated four methods of adjusting for structure
using PCs. Adjustment for the four PCs associated with
case status as linear covariates or for the cluster assign-
ments in logistic regression substantially reduces both
the genomic inflation factor and the significance level of
Table 3: Results for positive control SNPs for six methods of adjusting for structure
rs2476601 [11,12] rs3761847 [1]
Adjustment Method ba ± SE p-Value ba ± SE p-Value
A. Logistic regression adjusting for DRB 0.61 ± 0.11 3.70 × 10-8 0.42 ± 0.07 8.04 × 10-9
B. Logistic regression adjusting for DRB and PC1-4 0.47 ± 0.12 1.32 × 10-4 0.39 ± 0.08 2.08 × 10-6
C. Logistic regression adjusting for DRB and cluster 0.46 ± 0.12 1.57 × 10-5 0.45 ± 0.08 4.21 × 10-8
D. Logistic regression adjusting for DRB, PC1-4, and cluster 0.46 ± 0.13 2.44 × 10-4 0.42 ± 0.08 4.55 × 10-7
E. PSAT based on PC1-4 cluster ———b 1.17 × 10-6 ——— 2.80 × 10-8
F. Genomic control 0.16 ± 0.12 7.44 × 10-7 0.42 ± 0.08 2.22 × 10-7
Previously reported 0.50 ± 0.15 6.60 × 10-4 0.35 ± 0.04 4.00 × 10-14
ab, log-odds ratio for disease for the minor allele estimated by the logistic regression.
b—, Estimates of effect cannot be obtained.
Figure 2
Q-Q plot of -log10(p-value) for analyses. Quantile-
Quantile plot of -log10(p-value) for Methods A-F as described
in Methods. For each analysis, we plot the negative -log10(p-
value) for all genome-wide SNPs, excluding the SNPs in the
MHC. Black, Method (A) - logistic regression adjusting for
the DRB locus (inflation factor l = 1.24); Red, Method (B) -
logistic regression adjusting for the DRB locus and PC1-4 as
continuous covariates (l = 1.03); Green, Method (C) -
logistic regression adjusting for the DRB locus and PC cluster
(l = 1.04); Blue, Method (D) - logistic regression adjusting
for the DRB locus, PC1-4 as continuous covariates, and PC
cluster (l = 1.03); Purple, Method (E) - PSAT with disease
probability assigned based on clustering on PC1-4 (l = 1.15);
and Orange, Method (F) - genomic control using the logistic
model adjusting for the DRB locus (l = 1.00).
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the most highly associated SNPs (Figure 2), suggesting
that the structure that exists in this sample does result in
some bias. A criticism of adjusting for PCs as linear
covariates is that the PCs and disease frequency may not
be linearly related, especially when the PCs create
distinct clusters [9]. However, in this sample we found
that adjusting for either cluster assignment or PCs as
linear covariates in logistic regression produced similar
genomic inflation factor (l) and comparable effect
estimates for two specific positive control SNPs.
Although the PSAT randomization method has been
reported to provide improved power and better control
of type I error [9,10], in this sample the method
produced a considerably higher inflation factor for the
genome-wide test statistics than the other structure
adjustment methods (Figure 2). Because PSAT relies on
clustering individuals based on PCs or other distance
metrics, it may ultimately be more useful for accounting
for population structure at the cross-continent level,
rather than the more subtle structure observed in
populations of European descent.
Exploring existing genome-wide association study data
allows us to gain experience with methods for adjusting
for population structure under realistic conditions,
including variable LD due to inversion polymorphisms
and regions of highly associated SNPs. We have found
that population structure exists in the GAW16 RA data,
and that the structure is associated with case status.
Therefore, the association tests are potentially subject to
confounding by genetic ancestry. In this sample, we have
determined that the choice of SNP subset for PCA does
not substantively affect the resulting reduction in
genomic inflation factor for genome-wide association
analyses. However, for some SNP subsets, the PCs
associated with case status and used in the structure
adjustment heavily weighted small numbers of SNPs,
which could lead to reduced power to detect true
associations in those genomic regions. Thus, the SNP
set selected could have an impact on power. We
recommend that in practice, for studies with modest
levels of structure such as that expected when subjects are
all of European ancestry, investigators check the PCs that
will be used for structure adjustment for extreme weights
and choose alternative SNP sets if any genomic regions
are heavily weighted.
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